NCT04959604 Lymph Node Mapping Via Flourescent Dye in Colon Cancer
| NCT ID | NCT04959604 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitätsklinikum Hamburg-Eppendorf |
| Condition | Colon Carcinoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2021-05-31 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2021-05-31 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to evaluate whether lymph nodes draining the region of the carcinoma are located only inside the lines of standard resection or in some percentages are located outside as well. The visualized nodes draining the region of the carcinoma will be correlated to location, fluorescent yes/no and nodal positive/negative. The draining lymph nodes will be visualized using the fluorescent dye indocyanine green. The aim of the study is to evaluate whether lymph nodes draining the region of the carcinoma are located only inside the lines of standard resection or in some percentages are located outside as well. The visualized nodes draining the region of the carcinoma will be correlated to location, fluorescent yes/no and nodal positive/negative. The draining lymph nodes will be visualized using the fluorescent dye indocyanine green.
Eligibility Criteria
Inclusion Criteria: * histologically diagnosed carcinoma of the ascending, transverse, descending or sigmoid colon. Exclusion Criteria: * not wanting to participate * other carcinoma then adenocarcinoma * endoscopic marking not possible
Contact & Investigator
Daniel Perez, Prof. Dr.
PRINCIPAL INVESTIGATOR
Dept of General Visceral and Thoracic Surgery
Frequently Asked Questions
Who can join the NCT04959604 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Colon Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04959604 currently recruiting?
Yes, NCT04959604 is actively recruiting participants. Contact the research team at katharina.lucas@uni-wh.de for enrollment information.
Where is the NCT04959604 trial being conducted?
This trial is being conducted at Hamburg, Germany.
Who is sponsoring the NCT04959604 clinical trial?
NCT04959604 is sponsored by Universitätsklinikum Hamburg-Eppendorf. The principal investigator is Daniel Perez, Prof. Dr. at Dept of General Visceral and Thoracic Surgery. The trial plans to enroll 30 participants.